Sign In
Buy MED
$10.62
-0.400 (-3.63%)
At Close: Jun 23, 2026
Medifast Is A Net-Net With Negative Enterprise Value
10:26am, Wednesday, 04'th Feb 2026
Medifast trades below net cash, with an EV of -$43.68M, reflecting deep skepticism about its OPTAVIA MLM business and turnaround prospects. GLP-1 drugs have rendered MED's weight-loss model largely ob
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025
04:05pm, Tuesday, 03'rd Feb 2026
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quarter and full
Medifast's Q4 Guidance Remains Weak: When Does Growth Return?
01:31pm, Thursday, 22'nd Jan 2026
MED sees weak Q4 guidance after steep revenue declines, but a metabolic health pivot targets stabilization and recovery.
The Compliance Imperative: Regulatory Moats Driving 2026 Asset Re-Ratings
12:10pm, Monday, 19'th Jan 2026
/PRNewswire/ -- The global consumer healthcare market is hitting a massive structural wall, projected to reach $362.17 billion in 2026[1]. In this high-stakes
People Magazine Spotlights Tiffany Howard's Metabolic Health Journey with OPTAVIA®
08:30am, Friday, 16'th Jan 2026
BALTIMORE--(BUSINESS WIRE)--Medifast® (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system OPTAVIA, celebrates the inspiring health transformation
OPTAVIA® Premieres Second Docuseries Episode “Health by Design: Spain” Exploring Metabolic Health and Longevity
08:30am, Thursday, 15'th Jan 2026
BALTIMORE--(BUSINESS WIRE)--Medifast® (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system OPTAVIA, premiered its newest docuseries episode, “Hea
Medifast Shifts to Metabolic Health: A Durable Growth Path?
01:56pm, Thursday, 08'th Jan 2026
MED is pivoting to metabolic health, using clinical data and new products to address root causes beyond GLP-1 weight loss.
Medifast Announces Planned Leadership Transition
09:00am, Monday, 05'th Jan 2026
BALTIMORE--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED) today announced a planned leadership transition designed to provide continuity and stability as the company continues its evolution toward metabo
Medifast New Product Line Planned: Can Innovation Reignite Demand?
01:40pm, Tuesday, 30'th Dec 2025
MED plans a new product line rooted in metabolic synchronization science, upgrading its core offerings as it shifts beyond weight loss.
Medifast's Third-Quarter Revenue Fell 36%: Is Stabilization Near?
01:45pm, Wednesday, 24'th Dec 2025
MED witnesses revenue plunge as its coach base shrank, but restructuring and productivity initiatives aim to stabilize results by late 2025.
Can Medifast Overcome GLP-1 Pressure With Its Growth Strategy?
12:51pm, Thursday, 18'th Dec 2025
MED targets long-term metabolic health with programs that preserve muscle and support lasting wellness amid GLP-1 adoption.
Vital Farms (NASDAQ:VITL) versus Medifast (NYSE:MED) Critical Comparison
01:46am, Monday, 15'th Dec 2025
Medifast (NYSE: MED - Get Free Report) and Vital Farms (NASDAQ: VITL - Get Free Report) are both small-cap consumer staples companies, but which is the better investment? We will compare the two compa
BALTIMORE--(BUSINESS WIRE)--OPTAVIA, the science-backed, coach-guided lifestyle system, announced a new report “Metabolic Health in America: Awareness, Attitudes and Action.” The report includes f
Medifast (NYSE:MED) and BAB (OTCMKTS:BABB) Financial Survey
01:10am, Monday, 08'th Dec 2025
BAB (OTCMKTS:BABB - Get Free Report) and Medifast (NYSE: MED - Get Free Report) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two companies ba
Critical Comparison: Celsius (NASDAQ:CELH) versus Medifast (NYSE:MED)
03:46am, Saturday, 22'nd Nov 2025
Medifast (NYSE: MED - Get Free Report) and Celsius (NASDAQ: CELH - Get Free Report) are both consumer staples companies, but which is the superior stock? We will contrast the two companies based on th
